Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Sentinel Lymph Node Biopsy using Indocyanine green dye(ICG): The agent used for sentinel lymph node biopsy in the intervention arm will be Indocyanine Green dye(ICG) at the time of surg
Sponsors
Department of Surgical Disciplines
Eligibility
Inclusion criteria
Inclusion criteria: Upfront operable primary breast cancer measuring upto and including 5cm in maximum tumour dimension with clinically lymph node negative breast cancers (Tis, T1,T2-N0) undergoing upfront surgery Consenting patient
Exclusion criteria
Exclusion criteria: Pregnant or lactating women Patients who have received neo-adjuvant chemotherapy. Patients with history of previous surgery of axilla or chest wall. Patients with history of previous radiotherapy to the breast or axilla. H/o hypersensitivity to any of the agents used.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| identification and comparison of sentinel lypmh node proportions using Indocyanine green with the standard radio colloid- methylene blue dye method.Timepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Procedure time of doing sentinel lymph node biopsy from time of skin incision to identification of sentinel lymph node in each group.Timepoint: Baseline | — |
Countries
India
Contacts
Public ContactDr Nandury Bhargav Chandra
All India Institute of Medical Sciences, New Delhi
Outcome results
None listed